News

Early-stage clinical data with CanSino Biologics' inhaled COVID-19 vaccine show that it was able to stimulate neutralising antibodies against SARS-CoV-2 at a dose well below that required with ...
With her fiery red hair, striking figure, and unforgettable smile, it's no wonder Rita Hayworth became one of Hollywood’s ...
KUALA LUMPUR: The Health Ministry has approved CanSino’s single-dose Convidecia vaccine to be used as a heterologous booster with all Covid-19 primary vaccines in Malaysia. Solution Group Bhd ...
China's CanSino says its polio vaccine, developed with funding from the Bill & Melinda Gates Foundation, will help it turn a profit in the coming months. CEO Xuefeng Yu says 2024 was a challenging ...
CanSino has said it is also in talks with Russia, Brazil and Chile to launch Phase III trials in those countries. CanSino’s Hong Kong shares rose around 14 percent in Monday’s morning session.
A delegation from the Cansino laboratory has held meetings in Buenos Aires with Health Minister Carla Vizzotti and other officials to discuss local production of their COVID-19 vaccine ...
Get more of a good thing! Our weekly newsletter highlights our top stories, our special offers, and upcoming jazz events near you.
FILE PHOTO: Vials of a COVID-19 vaccine candidate, a recombinant adenovirus vaccine named Ad5-nCoV, co-developed by Chinese biopharmaceutical firm CanSino Biologics Inc and a team led by Chinese ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
In 2021, Tianjin-based biopharmaceutical company, CanSino Biologics (CanSinoBIO) completed a Phase III clinical trial of their intramuscular COVID-19 vaccine, which involved 45,000 volunteers ...